The global robotic endoscopy devices market size was estimated to be USD 3.03 billion in 2023 and is expected to reach at USD 22.76 billion by 2034 with a CAGR of 20.12% during the forecast period 2024-2034. Rising preference for minimally invasive surgical procedures, surge in product approvals by regulatory bodies, increasing prevalence of chronic diseases, growing focus on expanding product line by market players, rising number of robotic surgery procedures, surge in investments in technological innovations in endoscopy visualization systems by market players, and increasing technological advancements in robotic endoscopy devices are some of the key factors boosting the market growth.
Increasing technological advancements in robotic endoscopy devices is predicted to boost the market growth during the forecast period. These devices are designed to address the shortcomings of conventional diagnostic and therapeutic methods. Their advantages in surgical procedures encompass reduced post-surgery complications, faster recovery, and minimal scarring, consequently shortening hospital stays. These benefits linked to robotic endoscopy devices are expected to be a key driver for their widespread adoption. For instance, in March 2022, NVIDIA has introduced the AI computing platform called Clara Holoscan MGX Medical-Grade Platform, tailored for medical devices to implement and create real-time AI applications. This platform is anticipated to offer a comprehensive medical-grade reference architecture, expediting advancements in the medical device sector. Medical device manufacturers can seamlessly integrate Clara Holoscan MGX into their systems or connect it to their existing installed medical devices, thereby facilitating the swift deployment of AI and regulatory clearance for developers.
By product, therapeutic was the highest revenue-grossing segment in the global robotic endoscopy devices market in 2023 owing to the growing adoption of robotic endoscopy devices for surgical procedures, rising focus on developing novel robotic endoscopy devices for various surgical procedures by market players, and surge in introduction of the advanced robotic surgical system. Additionally, diagnostic is predicted to grow at fastest CAGR during the forecast period owing to the rising development & approvals of robotic endoscopy devices for various diagnostic procedures, increasing technological advancements, and growing regulatory approvals. For instance, in May 2022, A Johnson & Johnson subsidiary has received its second FDA clearance for the Monarch Robotic Surgery System, permitting the use of the robot in kidney stone removal procedures.
By application, laparoscopic was the highest revenue-grossing segment in the global robotic endoscopy devices market in 2023 owing to the surge in number of robotic laparoscopic surgeries, increasing geriatric population, rising demand for laparoscopic diagnostic & therapeutic procedures, growing launch of robotic platforms for bronchoscopy, and surge in research & development activities. For instance, in January 2022, A significant milestone has been achieved in the field of surgical automation, as a robot conducted laparoscopic surgery on a pig's soft tissue without human intervention. Developed by a group of researchers from Johns Hopkins University, this robot is known as the Smart Tissue Autonomous Robot (STAR) and is featured in today's edition of Science Robotics. Additionally, colonoscopy is predicted to grow at fastest CAGR during the forecast period owing to the significant abundance of devices in the developmental stage for colonoscopy applications, and rising prevalence of inflammatory bowel diseases such as Crohn’s disease, colorectal cancer & ulcerative colitis.
By end-user, hospitals was the highest revenue-grossing segment in the global robotic endoscopy devices market in 2023 owing to the growing adoption of hospitals as the primary care option, rising funding for hospitals, surge in number of robotic-assisted laparoscopy procedures, increasing patient awareness regarding the benefits of robotic systems, and growing adoption of robotic endoscopy devices for various types of surgical procedures. For instance, in August 2022, EndoQuest Robotics has successfully implemented its endoluminal surgical system (ELS) at Brigham and Women's Hospital (BWH) in Boston, MA. The ELS system is a revolutionary endoluminal robotic surgical platform that enables therapeutic endoscopists and surgeons to conduct scar-free upper and lower gastrointestinal surgeries with less invasiveness, utilizing either a trans-oral or trans-anal approach. Additionally, ambulatory surgical center is predicted to grow at fastest CAGR during the forecast period owing to the increasing adoption of robotic devices in ambulatory surgical centers, and growing patient preference for minimally invasive procedures.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in awareness regarding robot-assisted medical procedures, increasing demand for minimally invasive procedures, growing adoption of advanced technologies, and rising investment for the development of robotic endoscopy devices. For instance, in September 2022, Virtuoso Surgical has disclosed an investment of USD 20 million for the development of endoscopic surgical robots. These robotic systems will be employed in a wide range of surgical procedures, encompassing treatments for conditions such as bladder cancer, uterine fibroids, enlarged prostate, central airway obstruction removal, and endoscopic neurosurgery, among others. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing healthcare expenditure, rising prevalence of chronic diseases, surge in adoption of robotic systems in the healthcare facilities, and increasing research & development activities. For instance, in January 2023, Agilis Robotics (Agilis) has successfully concluded its second round of live animal testing using its in-house developed robot. Dr. Jason Y.K. Chan, the co-founder of Agilis RoboticsTM, performed the test with the company's second-generation device on a live pig specimen. The procedure involved the successful removal of artificial tumors using the en-bloc resection of bladder tumor (ERBT) technique.
Increasing technological advancements in robotic endoscopy devices is predicted to boost the market growth during the forecast period. These devices are designed to address the shortcomings of conventional diagnostic and therapeutic methods. Their advantages in surgical procedures encompass reduced post-surgery complications, faster recovery, and minimal scarring, consequently shortening hospital stays. These benefits linked to robotic endoscopy devices are expected to be a key driver for their widespread adoption. For instance, in March 2022, NVIDIA has introduced the AI computing platform called Clara Holoscan MGX Medical-Grade Platform, tailored for medical devices to implement and create real-time AI applications. This platform is anticipated to offer a comprehensive medical-grade reference architecture, expediting advancements in the medical device sector. Medical device manufacturers can seamlessly integrate Clara Holoscan MGX into their systems or connect it to their existing installed medical devices, thereby facilitating the swift deployment of AI and regulatory clearance for developers.
By product, therapeutic was the highest revenue-grossing segment in the global robotic endoscopy devices market in 2023 owing to the growing adoption of robotic endoscopy devices for surgical procedures, rising focus on developing novel robotic endoscopy devices for various surgical procedures by market players, and surge in introduction of the advanced robotic surgical system. Additionally, diagnostic is predicted to grow at fastest CAGR during the forecast period owing to the rising development & approvals of robotic endoscopy devices for various diagnostic procedures, increasing technological advancements, and growing regulatory approvals. For instance, in May 2022, A Johnson & Johnson subsidiary has received its second FDA clearance for the Monarch Robotic Surgery System, permitting the use of the robot in kidney stone removal procedures.
By application, laparoscopic was the highest revenue-grossing segment in the global robotic endoscopy devices market in 2023 owing to the surge in number of robotic laparoscopic surgeries, increasing geriatric population, rising demand for laparoscopic diagnostic & therapeutic procedures, growing launch of robotic platforms for bronchoscopy, and surge in research & development activities. For instance, in January 2022, A significant milestone has been achieved in the field of surgical automation, as a robot conducted laparoscopic surgery on a pig's soft tissue without human intervention. Developed by a group of researchers from Johns Hopkins University, this robot is known as the Smart Tissue Autonomous Robot (STAR) and is featured in today's edition of Science Robotics. Additionally, colonoscopy is predicted to grow at fastest CAGR during the forecast period owing to the significant abundance of devices in the developmental stage for colonoscopy applications, and rising prevalence of inflammatory bowel diseases such as Crohn’s disease, colorectal cancer & ulcerative colitis.
By end-user, hospitals was the highest revenue-grossing segment in the global robotic endoscopy devices market in 2023 owing to the growing adoption of hospitals as the primary care option, rising funding for hospitals, surge in number of robotic-assisted laparoscopy procedures, increasing patient awareness regarding the benefits of robotic systems, and growing adoption of robotic endoscopy devices for various types of surgical procedures. For instance, in August 2022, EndoQuest Robotics has successfully implemented its endoluminal surgical system (ELS) at Brigham and Women's Hospital (BWH) in Boston, MA. The ELS system is a revolutionary endoluminal robotic surgical platform that enables therapeutic endoscopists and surgeons to conduct scar-free upper and lower gastrointestinal surgeries with less invasiveness, utilizing either a trans-oral or trans-anal approach. Additionally, ambulatory surgical center is predicted to grow at fastest CAGR during the forecast period owing to the increasing adoption of robotic devices in ambulatory surgical centers, and growing patient preference for minimally invasive procedures.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in awareness regarding robot-assisted medical procedures, increasing demand for minimally invasive procedures, growing adoption of advanced technologies, and rising investment for the development of robotic endoscopy devices. For instance, in September 2022, Virtuoso Surgical has disclosed an investment of USD 20 million for the development of endoscopic surgical robots. These robotic systems will be employed in a wide range of surgical procedures, encompassing treatments for conditions such as bladder cancer, uterine fibroids, enlarged prostate, central airway obstruction removal, and endoscopic neurosurgery, among others. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing healthcare expenditure, rising prevalence of chronic diseases, surge in adoption of robotic systems in the healthcare facilities, and increasing research & development activities. For instance, in January 2023, Agilis Robotics (Agilis) has successfully concluded its second round of live animal testing using its in-house developed robot. Dr. Jason Y.K. Chan, the co-founder of Agilis RoboticsTM, performed the test with the company's second-generation device on a live pig specimen. The procedure involved the successful removal of artificial tumors using the en-bloc resection of bladder tumor (ERBT) technique.
Segmentation: Robotic Endoscopy Devices Market Report 2023 - 2034
Robotic Endoscopy Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Therapeutic
- Diagnostic
Robotic Endoscopy Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Colonoscopy
- Bronchoscopy
- Laparoscopy
Robotic Endoscopy Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Ambulatory Surgical Centers
- Hospitals
- Others
Robotic Endoscopy Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Robotic Endoscopy Devices Market: Product Estimates & Trend Analysis
8. Robotic Endoscopy Devices Market: Application Estimates & Trend Analysis
9. Robotic Endoscopy Devices Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Robotic Endoscopy Devices Market
12. Europe Global Robotic Endoscopy Devices Market
13. Asia Pacific Global Robotic Endoscopy Devices Market
14. Latin America Global Robotic Endoscopy Devices Market
15. MEA Global Robotic Endoscopy Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Johnson & Johnson (Auris Health Inc.)
- Asensus Surgical Inc.
- Olympus Corporation
- Medtronic PLC
- Brainlab AG
- Intuitive Surgical Inc.
- CMR Surgical Ltd
- Medrobotics Corporation
- Virtuoso Surgical
- Avatera Medical GmbH
- AKTORmed GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 3.03 Billion |
| Forecasted Market Value ( USD | $ 22.76 Billion |
| Compound Annual Growth Rate | 20.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
